Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie

Address:
Fahrstraße 17
91054 Erlangen



Subordinate Organisational Units

Professur für Klinische Pharmakologie


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 3 Go to next page Go to last page

Röhrig, W., Achenbach, S., Deutsch, B., & Pischetsrieder, M. (2019). Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS. Journal of Lipid Research, 60(8), 1475-1488. https://dx.doi.org/10.1194/jlr.D094680
Valina, C., Bömicke, T., Abdelrazek, S., Eltaweel, S., Stratz, C., Ferenc, M.,... Hochholzer, W. (2019). Pharmacodynamic safety of clopidogrel monotherapy in patients under oral anticoagulation with a vitamin K antagonist undergoing coronary stent implantation. Platelets, 30(6), 714-719. https://dx.doi.org/10.1080/09537104.2018.1506099
Schlichtig, K., Duerr, P., Dörje, F., & Fromm, F. (2019). Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety. In EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (pp. S18-S18). Stockholm, SE: HEIDELBERG: SPRINGER HEIDELBERG.
Taghikhani, E.P., Maas, R., Fromm, M., & König, J. (2019). The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine. PLoS ONE, 14(3). https://dx.doi.org/10.1371/journal.pone.0213747
Geßner, A., Mieth, M., Maas, R., & Fromm, M. (2019). Simultaneous quantification of 10 endogenous biomarkers of cardiovascular diseases and renal dysfunction in small volume plasma samples by LC-MS/MS. In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY: NEW YORK: SPRINGER.
Deutsch, B., Neumeister, C., Schwantes, U., Fromm, M., & König, J. (2019). Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium. Molecular Pharmaceutics, 16(2), 510-517. https://dx.doi.org/10.1021/acs.molpharmaceut.8b00779
Duerr, P., Schlichtig, K., Dörje, F., & Fromm, M. (2019). Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447)). In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY: NEW YORK: SPRINGER.
Haberkorn, B., König, J., & Fromm, M. (2019). Expression, localization and functional analysis of cancer type OATP1B3 in different stably transfected cell lines. In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY, DE: NEW YORK: SPRINGER.
Geßner, A., König, J., & Fromm, M. (2019). Clinical Aspects of Transporter-Mediated Drug–Drug Interactions. Clinical Pharmacology & Therapeutics. https://dx.doi.org/10.1002/cpt.1360
Zeitler, S., Ye, L., Andreyeva, A., Schumacher, F., Monti, J., Nürnberg, B.,... Friedland, K. (2019). Acid sphingomyelinase – a regulator of canonical transient receptor potential channel 6 (TRPC6) activity. Journal of neurochemistry. https://dx.doi.org/10.1111/jnc.14823
Geßner, A., Mieth, M., Auge, D., Chafai, A., Müller, F., Fromm, M., & Maas, R. (2019). Establishment of reference values for the lysine acetylation marker N ɛ-acetyllysine in small volume human plasma samples by a multi-target LC–MS/MS method. Amino Acids. https://dx.doi.org/10.1007/s00726-019-02765-8
Stratz, C., Geßner, A., Fromm, M., Hromek, J., Nuehrenberg, T., Hille, L.,... Trenk, D. (2018). Association of plasma concentration of trimethylamine N-oxide and ADP-induced platelet reactivity after a loading dose of clopidogrel 600 mg in patients undergoing elective PCI. In EUROPEAN HEART JOURNAL (pp. 678-678). Munich, DE: OXFORD: OXFORD UNIV PRESS.
Stopfer, P., Giessmann, T., Hohl, K., Hutzel, S., Schmidt, S., Gansser, D.,... Müller, F. (2018). Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions. British Journal of Clinical Pharmacology, 84(9), 1941-1949. https://dx.doi.org/10.1111/bcp.13609
Mueller, F., Sharma, A., König, J., & Fromm, M. (2018). Biomarkers for In Vivo Assessment of Transporter Function. Pharmacological Reviews, 70(2), 246-277. https://dx.doi.org/10.1124/pr.116.013326
Schlichtig, K., Lechner, P., Grafe, C., Ferstl, B., Fuchs, F., Hein, A.,... Dorje, F. (2018). Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN. (pp. 198-198).
Abe, O., Ono, T., Sato, H., Mueller, F., Ogata, H., Miura, I.,... Misaka, S. (2018). Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers. European Journal of Clinical Pharmacology, 74(6), 775-783. https://dx.doi.org/10.1007/s00228-018-2436-2
Ceckova, M., Reznicek, J., Deutsch, B., Fromm, M., & Staud, F. (2018). Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate). PLoS ONE, 13(8). https://dx.doi.org/10.1371/journal.pone.0202706
Mueller, F., Weitz, D., Mertsch, K., König, J., & Fromm, M. (2018). Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition. Molecular Pharmaceutics, 15(8), 3425-3433. https://dx.doi.org/10.1021/acs.molpharmaceut.8b00416
Grafe, C., Semrau, S., Hein, A., Beckmann, M., Mackensen, A., Dörje, F., & Fromm, M. (2018). Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety. Naunyn-Schmiedeberg's Archives of Pharmacology, 391(2), 219-229. https://dx.doi.org/10.1007/s00210-017-1456-2
Geßner, A., König, J., & Fromm, M. (2018). Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO). Scientific Reports, 8(1). https://dx.doi.org/10.1038/s41598-018-25139-8

Last updated on 2019-24-04 at 10:28

Share link